权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Civil Law Study on Genetic Medicine - Focusing on the English Law and the Swedish Law

基因医学民法研究——以英国法和瑞典法为中心

基本信息

批准号：
17530067
负责人：
ISOGAWA Naoyuki
金额：
$ 2.11万
依托单位：
Kyushu University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2005
资助国家：
日本
起止时间：
2005 至 2006
项目状态：
已结题

来源：
https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17530067/
关键词：
genetic medicine genetic information medical injury the patient doctor relationship patient's right English medical law medical law 遺伝子医療と法遺伝情報と法医事民法

项目摘要

The aims of this medico-legal research gather around the comparative legal study on gene tic medicine as a whole, including genetic testing genetic diagnosis, gene therapy, and clinical research on gene therapy. This research has also a special linkage with my former researches on the patient/doctor relationship. While continuously pursuing a study on the English medical law and the Swedish medical law as my preceding researches, this project newly set its course to the fundamental problems arising from the accidents/incidents during the medical practices using gene technology. After the basic study on the general backgrounds and practices of genetic medicine, the main issues to be tackled with were realized as follows. 1. Peculiarity of gene medicine: medical practice with genetic technique has some unique points contrasting to normal (non-genetic) medical practices or not. 2. Difference of stages on genetic medicine: something specials to be considered are found between genetic testing/therapy and genetic research or not. 3. Special problems: a genetic practice (for example, PGD) has own legal matters or not. In process of this research I had opportunities to visit and study further at the main British medico-legal centers including Cardiff Law School and at Uppsala University in Sweden, and could manage to collect so many essential materials on medical law as a whole. Main results from this research are as follows. 1. Genetic medicine basically has common legal settings with normal (non-genetic) medical practices except for genetic information. 2. In case of genetic research the patient/supplier of materials must be highly protected. 3. Special problems: some cases (including PGD case, right-not-to-know case) are worth studying further. As the next research schedule, inter alia, a promotion of fundamental study on the legal aspects of the genetic information, for instance, should be highly expected along the line of these research projects.

本医学法律的研究的目的是围绕基因医学的比较法律的研究，包括基因检测、基因诊断、基因治疗和基因治疗的临床研究。本研究与本人以往对医患关系的研究也有着特殊的联系。在继续进行研究的英国医疗法和瑞典的医疗法作为我以前的研究，这个项目新设置的过程中产生的事故/事件在医疗实践中使用基因技术的基本问题。在对遗传医学的一般背景和实践进行了基础研究之后，认识到需要解决的主要问题如下。1.基因医学的特殊性：基因技术的医疗实践与常规（非基因）医疗实践相比具有一些独特之处。2.基因医学的阶段差异：基因检测/治疗和基因研究之间有一些特殊的地方需要考虑。3.特殊问题：遗传学实践（例如，PGD）是否有自己的法律的事项。在研究过程中，我有机会到英国主要的医学法律中心，包括卡迪夫法学院和瑞典乌普萨拉大学进行进一步的访问和研究，并设法收集了许多关于医学法律的基本材料。本研究的主要结果如下。1.遗传医学基本上与正常（非遗传）医疗实践具有共同的法律的设置，但遗传信息除外。2.在基因研究的情况下，患者/材料供应商必须受到高度保护。3.特殊问题：有些案例（包括PGD案例、知情权案例）值得进一步研究。沿着这些研究项目的路线，作为下一个研究计划，应该高度期待促进对遗传信息的法律的方面的基础研究。